Company

Atavistik Bio

Biotechnology Research Cambridge, Ma, United States 38 employees

Employees: 38
Contacts: 4
Emails: 4
Phones: 3

atavistikbio.com LinkedIn Crunchbase

Atavistik Bio Overview

Headquarters: Cambridge, Ma, United States
Website: atavistikbio.com
Industry: Biotechnology Research
Employees: 38
Founded: 2021
Funding: 40.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

to our country. Wishing everyone a safe and restful holiday as we reflect on their bravery and sacrifice.

About Atavistik Bio

Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology. Since its inception, Atavistik Bio has rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. ATV-1601, a selective allosteric inhibitor for solid tumors, is anticipated to enter the clinic in early 2025. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, and Lux Capital.

Atavistik Bio Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Atavistik Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Bingsong Han	Senior Director of Medicinal Chemistry at Atavistik Bio	Greater Boston, United States	Email
Lindsay Duhaime	Head of Operations at Atavistik Bio	Cambridge, Massachusetts, United States	Email Phone
John Josey	Venture Partner at the Column Group	Dallas, Texas, United States	Email Phone
Jeff Goater	Partner at the Column Group	Greater Boston, United States	Email Phone